Twitter | Search | |
Search Refresh
The NASH Education Program Sep 20
Gut Microbe Linked to 👉 "Researchers have identified one possible cause of , a common disorder in which fat builds up in the w/ potentially life-threatening downstream effects, including inflammation, & ."
Reply Retweet Like
Intercept Pharma 3m
? More than half of patients say there isn't enough information available to them about their disease. Learn more about support groups and how to find answers to your questions:
Reply Retweet Like
Hitesh Inamke 8h
One of the nash community members has made a graphics telling what has achieved till date.
Reply Retweet Like
Andy Biotech Sep 19
Alcohol-producing gut bacteria could cause liver damage even in people who don't drink Oh man, "That’s equivalent to 15 shots of 40% [80-proof] whisky." Blame your for fatty liver
Reply Retweet Like
DR3WCURRENCY Sep 22
Selling token...DM me
Reply Retweet Like
Nash Boy Sep 19
volume is increasing slightly but still negligible. Let's see if the fiat ramps will change that. If there are people who have already used the US ramps, please provide Fabio with feedback on the Nash community website:
Reply Retweet Like
Janis Alltag Sep 16
I do not understand investors complaining about low trading volume on the Nash exchange. I mean it`s all in your hands ! Just fill the order books with your desired offers and lean back - and realize: low volume also means no shady trading bots and wash trading!
Reply Retweet Like
AASLD Sep 21
From : "Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis"
Reply Retweet Like
Sunil Bhuyan ⋰·⋰ Sep 21
Love this project to the core!!
Reply Retweet Like
Fatty Liver Fix Sep 21
Nonalcoholic steatohepatisis () is one of the leading causes of cirrhosis.
Reply Retweet Like
Ana Sanchez Bao Sep 21
This study founds that 1/3 patients with NAFLD and fibrosis (SF) have NOT NASH❗️Dissociation between NASH and SF is more marked in severely obese patients. The severity of steatosis and the PNPLA3 I148M variant predicted SF.
Reply Retweet Like
Caitlin Halbert Sep 21
So humbled to be asked to share my passion at the Christiana Care GI Symposium. And...it’s the first time I’ve announced my new role as the Medical Director!!!
Reply Retweet Like
Daniel J Drucker 5h
Mangelsdorf Insights into FGF21. Central vs. Peripheral, Pharmacology vs. Physiology, Beware Bone Resorption Blood Pressure HPA Axis. Acute actions on WAT, Chronic via CNS
Reply Retweet Like
US Radiology Specialists 2h
We applaud the FDA for awarding  $250K to qualify its proprietary biomarkers for in collab w Dr. Naim Alkhouri at the Texas Liver Institute. The study begins recruiting next year & participants will be scanned at ’s MRI facility in San Antonio.
Reply Retweet Like
Fatty Liver Fix Sep 21
A recent study showed that weight loss of at least 9% over a period of months can help reverse .
Reply Retweet Like
GlobalLiverInstitute Sep 18
Perspectum Announces FDA Grant Award for LiverMultiScan to Help NASH Patients
Reply Retweet Like
Ana Sanchez Bao Sep 21
Best of : Dr Cusi proposal of how to use pioglitazone in patients with T2DM and
Reply Retweet Like
David Marti Aguado 20h
Happy to present our digital pathology work at ; . See you this week in Sevilla .
Reply Retweet Like
Jose Fco AP 2h
Replying to @fiebsy @nashsocial
I love but this new can be fake. There isn't official telegram channel. Fabio did not say this on Nash community or Twitter. It's easy to create fake account
Reply Retweet Like
Dončić NO1 Fans Sep 18
So much talent, only 1 picture!
Reply Retweet Like

Related searches

@nashsocial